Diabetic Cardiomyopathy (DCM) is characterized by myocardial dysfunction caused by
diabetes mellitus. After-effects of diabetic cardiomyopathy are far more lethal than non …

To profile microRNAs population of glucose-induced cardiomyoblast cell line and identify
the differentially expressed microRNAs and their role under pre-diabetes and diabetes …

Diabetic cardiomyopathy is characterized as abnormal function and structure of myocardium
associated with diabetes irrespective of other cardiac risk factors like hypertension or …

Cardiac fibrosis is one of the main characteristics of diabetic cardiomyopathy and manifests
excessive accumulation of extracellular matrix proteins in the heart. Several signaling …

The risk of heart failure is 2-5 times higher in diabetic patients as compared to non-diabetic
patients with similar comorbidities. Recent reports suggest that nearly half of the diabetic …

Little is known about the mechanism of prediabetes-induced cardiac dysfunction. Therefore,
we aimed to explore key molecular changes with transcriptomic and bioinformatics …

Introduction Diabetic cardiomyopathy (DCM) is an end-point macrovascular complication
associated with increased morbidity and mortality in 12% of diabetic patients. MicroRNAs …

Persistent hyperglycemia in diabetic patients has been associated with cardiac hypertrophy,
myocardial fibrosis and cardiac dysfunction. However, the underlying mechanisms of this …

Type 2 diabetes mellitus (T2DM) and its complications pose a serious threat to the life and
health of patients around the world. The most dangerous complications of this disease are …

The increasing morbidity and mortality of type 2 diabetic mellitus (T2DM) patients with
ischemic heart disease (IHD) highlight an urgent need to identify early biomarkers, which …